Results for: Price Fixing

Teva Pharmaceuticals has agreed to a $450 million settlement with the U.S. government to resolve allegations of violating the Anti-Kickback Statute and False Claims Act. The settlement stems from accusations that Teva engaged in two unlawful kickback schemes involving the multiple sclerosis drug Copaxone and price-fixing of generic drugs. This settlement is the largest among a series of cases targeting pharmaceutical companies for unlawfully paying patient copays through third-party foundations.

Texas Attorney General Ken Paxton has filed a lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), accusing them of conspiring to inflate insulin prices. The lawsuit alleges that manufacturers artificially raised prices while paying PBMs for preferred placement, ultimately harming diabetes patients and healthcare providers.

The U.S. Department of Justice is investigating German software giant SAP and its U.S. reseller, Carahsoft Technology, for potential price-fixing schemes involving billions of dollars worth of software sold to government agencies. The investigation focuses on potential bid-rigging and overcharging for SAP technology sold to the U.S. military and government agencies since 2014.

Residents of Washington state who purchased chicken or tuna products from certain companies may be eligible for a rebate of up to $120 as part of a major settlement. The state alleges that over 20 companies artificially inflated prices on canned tuna and chicken items, resulting in overpayments by consumers. The settlement distributes funds to low-income individuals making less than 175% of the federal poverty level, with single-person households receiving $50 and households with two or more individuals receiving $120.